SLC31A1 and adrenal cortex carcinoma: In individuals diagnosed with adrenocortical carcinoma (ACC), low-grade glioma, or mesothelioma (MESO), heightened expression levels of SLC31A1 were correlated with diminished overall and disease-free survival rates.